Showing results (71-80 of 77) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Gut|April 11, 2006
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trialG Van Assche, W J Sandborn, B G Feagan, et al.Gut|August 25, 2009
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitisI Arijs, K Li, G Toedter, et al.Alimentary Pharmacology & Therapeutics|June 20, 2018
An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's diseaseF Rieder, D Bettenworth, C Ma, et al.Alimentary Pharmacology & Therapeutics|July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel diseaseR Khanna, B D Sattin, W Afif, et al.Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.Journal of Crohn'S & Colitis|April 16, 2013
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelinesJ Panes, Y Bouhnik, W Reinisch, et al.The American Journal of Gastroenterology|August 26, 2015
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetL Peyrin-Biroulet, W Sandborn, B E Sands, et al.Pageof 8